July 09, 2019
CytomX Therapeutics
CytomX Therapeutics Announces Second Target Selection and Program Initiation with AbbVie Under Ongoing, Multi-Program Strategic Oncology Collaboration
July 09, 2019
Celsius Therapeutics
Celsius Therapeutics Signs Collaboration Agreement with Janssen to Identify Response Biomarkers for Ulcerative Colitis
July 08, 2019
Tango Therapeutics
Tango Therapeutics Appoints Reid Huber, Ph.D., to Board of Directorsta
July 03, 2019
Sage Therapeutics
Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)